Format

Send to

Choose Destination
J Pharm Sci. 2008 Dec;97(12):5080-3. doi: 10.1002/jps.21364.

PATH's approach to product introduction in developing countries.

Author information

1
PATH, Technology Solutions, Program Officer, 1455 NW Leary Way, Seattle, Washington 98107, USA. charner@path.org

Abstract

Health interventions developed for wealthy nations are difficult to introduce in developing countries due to a lack of sufficient technological, financial, political, or infrastructural resources. Increasingly, however, product developers are creating new technologies that meet the needs of low-resource settings. Experience has shown that many activities must be undertaken to prepare health systems to accept and embrace new, improved, or under-utilized health technologies. This article describes three health technologies--a diagnostic test for vitamin A deficiency, new cervical cancer vaccines, and the vaccine vial monitor--that PATH, a global health organization, has helped advance for developing-country markets.

PMID:
18404650
DOI:
10.1002/jps.21364
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center